Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Radical Halogenation and Catalytic Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109020872B details a novel method converting unwanted paroxetine isomers into valuable racemic intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.